Thomas J. Riga
2021
In 2021, Thomas J. Riga earned a total compensation of $2.8M as President and Chief Executive Officer at Spectrum Pharmaceuticals, a 11% increase compared to previous year.
Compensation breakdown
| Bonus | $364,000 |
|---|---|
| Option Awards | $1,290,829 |
| Salary | $550,000 |
| Stock Awards | $478,500 |
| Other | $105,528 |
| Total | $2,788,857 |
Riga received $1.3M in option awards, accounting for 46% of the total pay in 2021.
Riga also received $364K in bonus, $550K in salary, $478.5K in stock awards and $105.5K in other compensation.
Rankings
In 2021, Thomas J. Riga's compensation ranked 4,717th out of 12,405 executives tracked by ExecPay. In other words, Riga earned more than 62.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,717 out of 12,405 | 62nd |
Division Manufacturing | 1,964 out of 5,494 | 64th |
Major group Chemicals And Allied Products | 824 out of 2,369 | 65th |
Industry group Drugs | 737 out of 2,090 | 65th |
Industry Pharmaceutical Preparations | 525 out of 1,537 | 66th |
Pay ratio
| Thomas J. Riga's Pay | $2,788,857 |
|---|---|
| Median Employee's Pay | $158,327 |
| Pay Ratio | 18to 1 |
In 2021, the annual total compensation of Thomas J. Riga was $2,788,857.
The annual total compensation of the median employee at Spectrum Pharmaceuticals was $158,327.
The ratio of Thomas J. Riga's pay to the pay of median employee was therefore 18 to one.
Source: SEC filing on April 27, 2022.
Riga's colleagues
We found four more compensation records of executives who worked with Thomas J. Riga at Spectrum Pharmaceuticals in 2021.